- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A study to evaluate the safety, tolerance and changes in blood levels of an anti-toxin drug (FBT-002) in healthy male and female subjects
This study is testing a new medicine, FBT-002, in healthy people for the very first time. We want to see if it's safe, how much the body can handle, and how it moves through the bloodstream. It's an early step in developing a medicine that could act as an antidote.
France - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
[HIBOU] : A phase I, single-center, randomized, double-blind, single-dose escalation, placebo-controlled clinical study to evaluate the safety, tolerability and pharmacokinetics of IMP21052 administered intravenously in three groups of healthy male and female volunteers
This early-stage study is looking for healthy adults to test a new medicine called IMP21052. We want to see if it's safe, how well people tolerate it, and how the body handles it. It's a single dose given intravenously.
France